Company intelligence / Profile preview

Seminal Biosciences

Solon, Ohio, United Statesseminalbioscience.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Seminal Biosciences has developed a proprietary process using synthetic biology and precision fermentation to produce cocoa butter without cacao beans. The technology is at pilot scale with test articles produced and aims to launch its first commercial product—a cacao-free cocoa butter alternative—in 2024. The company’s approach offers sustainability benefits by reducing reliance on traditional agriculture and improving supply chain security for chocolate manufacturers.

Modalities: Precision fermentationSynthetic biology platform for specialty fats production
Industry: Non-Drug Biotech

Partnerships

Nucelis LLC – collaboration on microbial strain development and prototype refinement

Beyond the preview

Go deeper on Seminal Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seminal Biosciences.

Explore the full profile